Skip to main content
TipRanks
Go Ultimate75% OFF

Qyuns Therapeutics Co., Ltd. Class H (2509) Financial Statements

1 Followers

Qyuns Therapeutics Co., Ltd. Class H Financial Overview

Qyuns Therapeutics Co., Ltd. Class H's market cap is currently ¥3.27B. The company's EPS TTM is ¥2.42; its P/E ratio is 5.04; Qyuns Therapeutics Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 786.08M¥ 158.79M¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit¥ 664.66M¥ 92.19M¥ -32.96M¥ 9.66M¥ -9.56M
Operating Income¥ 319.74M¥ -326.37M¥ -504.51M¥ -293.69M¥ -168.62M
EBITDA¥ 351.83M¥ -309.62M¥ -484.12M¥ -293.62M¥ -153.70M
Net Income¥ 306.31M¥ -335.57M¥ -507.75M¥ -298.19M¥ -411.04M
Balance Sheet
Cash & Short-Term Investments¥ 1.04B¥ 556.55M¥ 377.25M¥ 689.57M¥ 620.44M
Total Assets¥ 1.60B¥ 983.88M¥ 795.58M¥ 1.16B¥ 1.07B
Total Debt¥ 580.26M¥ 527.60M¥ 346.06M¥ 295.25M¥ 290.26M
Net Debt¥ -381.90M¥ 166.91M¥ 129.76M¥ 82.16M¥ 72.21M
Total Liabilities¥ 921.62M¥ 762.83M¥ 494.63M¥ 373.69M¥ 363.33M
Stockholders' Equity¥ 694.33M¥ 228.98M¥ 294.76M¥ 641.72M¥ 670.35M
Cash Flow
Free Cash Flow¥ 392.23M¥ -187.85M¥ -308.63M¥ -301.70M¥ -228.64M
Operating Cash Flow¥ 399.85M¥ -186.09M¥ -300.68M¥ -225.21M¥ -122.58M
Investing Cash Flow¥ 118.69M¥ -25.23M¥ 243.11M¥ -5.70M¥ -247.42M
Financing Cash Flow¥ 93.73M¥ 351.81M¥ 61.21M¥ 211.49M¥ 281.48M

Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

-600M0600M1.2B-4000 %-2000 %0 %2000 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin

Qyuns Therapeutics Co., Ltd. Class H Liabilities to Assets

0600M1.2B1.8B20 %40 %60 %80 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets

Qyuns Therapeutics Co., Ltd. Class H Cash Flow

-400M-200M0200M400M600M20212022202320242025OperatingInvestingFinancing

Qyuns Therapeutics Co., Ltd. Class H Forecast EPS vs Actual EPS

-2-1012Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss